F552 in Wisconsin. Pick another state for the same tag.
Against expectation — 2025
Wisconsin cites F552 more often than its own record predicts
Versus expected share1.01×
1.01 times the share F552 takes of citations nationally.
Share of Wisconsin citations0.55%
Of every deficiency written in Wisconsin in 2025, this is the portion that was F552.
Wisconsin0.55%
National0.54%
Share of all citations that were F552.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Wisconsin surveyors wrote
F552 findings written in Wisconsin, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedJuly 22, 2026
Based on interview and record review, the facility did not ensure 1 resident (R) (R1) of 6 sampled residents or their legal representative was informed in advance of the risks and benefits of prescribed medication and provided consent to receive the medication.R1 was prescribed Sertraline (antidepressant medication). R1 was not informed of the risks and benefits and did not consent to receive the medication. Findings include:The facility's Psychotropic Management policy, dated December 2025, indicates: A psychotropic medication is considered a chemical restraint when it is used as the first intervention to control behavior, mood, or mental status. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction